Abstract:Abstract MicroRNAs (miRNAs) are small non coding RNAs of about 22 nucleotides in length, which regulate their target gene expression by binding to the 3′ UTR of mRNA. Recent studies have shown that some miRNAs are regulated by DNA methylation and aberrant miRNA gene methylation contributes to human tumorigenesis. In this study, we used real-time quantitative methylation-specific PCR to detect a panel of miRNA methylation in tumor and adjacent normal tissues from surgically resected lung cancer patients. We found significantly higher methylation levels of miR-124a family, miR-126, miR-193a, miR-9 family, and miR-34b/c in tumor tissues (N=107) than in normal tissues (N=19, P<0.05), but no significant difference was found for miRNA-137 and miRNA-148a. The methylation levels of four miRNAs (miRNA-124a3, miRNA-148a, miR-9-3, and miR-34b/c) were higher in tumors from older patients than those from younger patients. MiR-9-1 (29.56±29.51) and miR-9-3 (30.49±28.50) had higher methylation in tumors from current smokers than never smokers (15.77±15.28 and 10.71±11.32, P=0.036 and 0.021, respectively). There were no significant differences in methylation levels of these four miRNAs between tumors from men and women. Hypermethylation of miR-9-1, miR-9-3, miR-34b/c and miR-148a was associated with significantly better survival with hazard rations of 0.35 (95% CI, 0.17-0.72), 0.48 (95% CI, 0.25-0.91), 0.52 (95% CI, 0.27-0.99), and 0.52 (95% CI, 0.28-0.98), respectively. Our results demonstrated that selected miRNAs are hypermethylated in lung cancer and miRNA hypermethylation might be a useful biomarker in detection and prognosis of lung cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4092.

Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Methylation Modification is a Poor Prognostic Factor in Non-Small Cell Lung Cancer and Regulates the Tumor Microenvironment: Mrna Molecular Structure and Function

Aberrant Mirna Methylation In Tumors From Surgically Resected Lung Cancer Patients And Association With Survival

Epigenetic Analysis of Microrna Genes in Tumors from Surgically Resected Lung Cancer Patients and Association with Survival

Decreased Mirna-148a is Associated with Lymph Node Metastasis and Poor Clinical Outcomes and Functions As A Suppressor of Tumor Metastasis in Non-Small Cell Lung Cancer

[Methylation Status of Mir-182 Promoter in Lung Cancer Cell Lines].

DNA Methylation Mediated Silencing of Microrna-145 is a Potential Prognostic Marker in Patients with Lung Adenocarcinoma

Correlation between methylation status of tumor-related genes and mRNA transcriptional level in lung cancer cell lines.

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Promoter Methylation of Wnt/β-Catenin Signal Inhibitor TMEM88 is Associated with Unfavorable Prognosis of Non-Small Cell Lung Cancer.

Promoter Methylation of APC and RAR-β Genes As Prognostic Markers in Non-Small Cell Lung Cancer (NSCLC)

Analysis of Methylation Status of RASSF1A promoter Region and Transcription Level of Downstream Genes in Non-Small Cell Lung Cancer

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

Gene Regulation and Prognostic Indicators of Lung Squamous Cell Carcinoma: TCGA-derived Mirna/mrna Sequencing and DNA Methylation Data.

Up-regulation of miR-1825 p predicts poor prognosis in patients with lung cancer and associates with tumor cell growth and migration

Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9

Quantitative Assessment of Gene Promoter Methylation in Non-Small Cell Lung Cancer Using Methylation-Sensitive High-Resolution Melting.

DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer.

Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients

Aberrant Promoter Methylation of FBLN-3 Gene and Clinicopathological Significance in Non-Small Cell Lung Carcinoma.